NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-NS-23-093 from the NIH Guide for Grants and Contracts
Notice NOT-HG-23-046 from the NIH Guide for Grants and Contracts
Notice NOT-NS-23-091 from the NIH Guide for Grants and Contracts
Notice NOT-DC-23-013 from the NIH Guide for Grants and Contracts
Notice NOT-CA-23-077 from the NIH Guide for Grants and Contracts
Notice NOT-RM-23-020 from the NIH Guide for Grants and Contracts
Notice NOT-HL-23-090 from the NIH Guide for Grants and Contracts
Notice NOT-TR-23-025 from the NIH Guide for Grants and Contracts
Notice NOT-DA-23-029 from the NIH Guide for Grants and Contracts
Notice NOT-AG-23-038 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-OD-23-018 from the NIH Guide for Grants and Contracts. The NIH Office of Disease Prevention (ODP) and participating Institutes, Centers, and Offices are soliciting T32 applications to train predoctoral scholars from diverse backgrounds, including those underrepresented in prevention relevant fields, in three integrated areas: 1) health disparities/health equity research, 2) development and implementation of multi-level preventive interventions, and 3) methods for the design and analysis of studies to evaluate multi-level preventive interventions (see Notice of NIH's Interest in Diversity).
Funding Opportunity RFA-ES-23-011 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) is intended to support novel environmental health research in which an unpredictable event or policy change provides a limited window of opportunity to collect human biological samples or environmental exposure data. The primary motivation of the FOA is to understand the consequences of natural and human-made disasters, emerging environmental public health threats, and policy changes in the U.S. and abroad. A distinguishing feature of an appropriate study is the need for rapid review and funding, substantially shorter than the typical NIH grant review/award cycle, for the research question to be addressed and swiftly implemented.
Funding Opportunity RFA-AG-24-048 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support research that can lead to the development of evidence-based primary care screening tools and behavioral interventions to prevent abuse in at-risk older and vulnerable adults with mild cognitive impairment (MCI) and Alzheimers disease (AD) and Alzheimer's disease-related dementias (ADRD) and their families.
Funding Opportunity RFA-TR-23-016 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition to preclinical efficacy, accompanying pharmacodynamic and pharmacokinetic studies would be supported. Therapeutic agents include small molecules, biologics or biotechnology-derived products. The goal of this NOFO is to spur therapeutic development for rare diseases by advancing projects to the point where they would attract subsequent investment supporting full Investigational New Drug (IND) application development or progression to clinical trials in the case of repurposing or repositioning.
Funding Opportunity RFA-AG-24-039 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications to develop and validate the standardized protocols for measuring nicotinamide adenine dinucleotide (NAD+) and related metabolites levels in humans, including sample collection and storage, assays calibration, and standardization of measurements across different types of samples such as plasma, tissue, or serum extracts, and validation of these protocols. Limited preclinical animal studies could be proposed by the applicants, if such studies are integral part of the applications and if they are needed to test the select elements of the standardized protocols in animal models before such protocols could be tested in humans. The proposed studies will be funded by individual awards, but the awardees will be required to interact as a network to exchange information, discuss their progress, pitfalls and issues arising during studies implementation.
Funding Opportunity RFA-EB-23-003 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support the NeuroImaging Tools and Resources Collaboratory and to enable collaborative research in neuroimaging informatics. The competition is limited to the U24 awardees and subawardees of RFA-EB-16-002.
Notice NOT-AG-23-041 from the NIH Guide for Grants and Contracts
Notice NOT-AG-23-036 from the NIH Guide for Grants and Contracts
Notice NOT-DA-23-028 from the NIH Guide for Grants and Contracts
Notice NOT-DA-23-026 from the NIH Guide for Grants and Contracts